Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. BiomX Inc. shares valued at $567 were sold by Ugwumba Chidozie on Nov 04. At $0.38 per share, Ugwumba Chidozie sold 1,501 shares. The insider’s holdings dropped to 2,997,025 shares worth approximately $1.02 million following the completion of this transaction.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Also, Ugwumba Chidozie sold 2,000 shares, netting a total of over 732 in proceeds. Following the sale of shares at $0.37 each, the insider now holds 2,998,526 shares.
Before that, Ugwumba Chidozie had sold 2,416 shares from its account. In a trade valued at $867, the Exit Form 4 – former 10% owner traded BiomX Inc. shares for $0.36 each. Upon closing the transaction, the insider’s holdings decreased to 2,416 shares, worth approximately $1.02 million.
As published in their initiating research note from Ladenburg Thalmann on April 15, 2021, BiomX Inc. [PHGE] has been a Buy and the price target has been revised to $25. This represents a 98.64% premium over Wednesday’s closing price.
Analyzing PHGE Stock Performance
On Wednesday, BiomX Inc. [AMEX: PHGE] plunged -1.85% to $0.34. The stock’s lowest price that day was $0.29, but it reached a high of $0.34 in the same session. During the last five days, there has been a drop of approximately -3.71%. Over the course of the year, BiomX Inc. shares have jumped approximately 80.50%. Shares of the company reached a 52-week high of $0.4398 on 02/02/23 and a 52-week low of $0.1811 on 01/03/23. A 50-day SMA is recorded $0.2758, while a 200-day SMA reached $0.5041. Nevertheless, trading volume fell to 0.62 million shares from 92700.0 shares the previous day.
Support And Resistance Levels for BiomX Inc. (PHGE)
According to the 24-hour chart, there is a support level at 0.3057, which, if violated, would cause prices to drop to 0.2743. In the upper region, resistance lies at 0.3527. The next price resistance is at 0.3683. RSI (Relative Strength Index) is 52.77 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0069, which suggests the price will decrease in the coming days. Percent R is at 64.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is BiomX Inc. subject to short interest?
Stocks of BiomX Inc. saw a sharp steep in short interest on Jan 12, 2023 dropping by 62270.0 shares to 0.12 million. Data from Yahoo Finance shows that the short interest on Dec 14, 2022 was 0.18 million shares. A decline of -54.08% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.11 of the overall float, the days-to-cover ratio (short ratio) decline to 0.11.
Which companies own the most shares of BiomX Inc. (PHGE)?
According to MM Asset Management, Inc. filings, the company currently owns 684,451 shares, which is about 2.28% of the total PHGE shares outstanding. With the completion of the buy transaction, Millennium Management LLC’s stake is now worth $101,026. A total of 41,409 shares of BiomX Inc. were sold by G1 Execution Services LLC during the quarter, and 9,100 were bought by Renaissance Technologies LLC. In its current portfolio, UBS Securities LLC holds 29,893 shares valued at $11150.0.